San Francisco—Two proteins linked to tumor invasion and metastasis can help identify women with breast cancer whose risk of recurrence is low enough that they may want to consider forgoing chemotherapy, according to new research presented here at the American Society of Clinical Oncology (ASCO) annual meeting.
The researchers say that these findings, along with new data from a prospective clinical trial, are convincing enough to recommend routine testing for the two proteins to help determine treatment strategy, particularly for breast cancer patients whose axillary lymph nodes show no sign of cancer cells.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Table 9.2-2 Refuted Evidence From Studies of Physiologic or Surrogate Endpoints
The Rational Clinical Examination
Make the Diagnosis: Breast Cancer
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.